Results 1 to 5 of 8

Finding Uninjured Consumers In Drug Antitrust Class Actions

USA - May 16 2022 In an amicus brief filed in March opposing an appeal from end payers seeking to certify a class of end purchasers of the cholesterol drug Niaspan in…

Tram Nguyen

The Rise of COVID-19 Price Gouging Class Actions and the Economics of Class Certification

USA - September 3 2020 In response to the COVID-19 pandemic, governors and mayors across the United States have made…

Matthew Milner

Lamictal and the Myth of “Generic” “Pay-for-Delay” Cases

USA - July 24 2020 On April 22, 2020, the US Court of Appeals for the Third Circuit overturned a district court decision certifying a class of direct purchaser…

Tram Nguyen

Are Pandemic Sellers Actually Violating Price-Gouging Laws?

USA - April 3 2020 As COVID-19 spreads throughout the country, it is especially important unscrupulous sellers do not take advantage of Americans by selling products at…

Dr. John H. Johnson, IV, Matthew Milner

Taking a “Byte” Out of Antitrust Data Discovery: The Top 10 “Bits”

USA - February 27 2020 In many antitrust cases, economists use transactional data and related information to conduct economic analyses and form opinions on antitrust impact…

Matthew Milner